Helus Pharma Stock Performance
as on January 3, 2026 at 7:59 am IST
Day's Low
Day's High
$8.14$8.38
2.16%
Downside
0.72%
Upside

52 Week's Low
52 Week's High
$5.50$9.12
33.89%
Downside
9.62%
Upside

Helus Pharma share price movements today
- Previous Close
- $8.18
- Open
- $8.27
- Volume
- 874.9K
- Day's Low - High
- $8.14 - $8.38
- 52 Week Low - High
- $5.50 - $9.12
Helus Pharma Historical Returns
- 1 Month Return
- 0 %
- 3 Month Return
- 0 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Helus Pharma Stock Fundamentals & Key Indicators
Check Helus Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0.00
EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Helus Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Helus Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $- | NA | NA | 0.00% | 0.00% | |
| StrongBuy | $20.4B | 247.69% | -22.72 | 83.27% | 0.00% | |
| StrongBuy | $30.0B | 13.31% | 36.73 | 79.72% | 0.00% | |
| StrongBuy | $132.8B | 184.64% | 30.25 | 86.04% | 0.00% | |
| Buy | $82.9B | 35.95% | 19.22 | 84.86% | 0.46% |
Analyst Recommendation on Helus Pharma Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Helus Pharma. Average target price of $48.04
Helus Pharma Share Price Target
Get share price movements and forecasts by analysts on Helus Pharma.
What analysts predicted
82.68%UPSIDE
Target Price
$48.04
Current Price
$8.32
Analyzed by
7 Analysts
Target
$48.04
Helus Pharma target price $48.04, a slight upside of 82.68% compared to current price of $8.32. According to 7 analysts rating.
Helus Pharma Quarterly Profit & Loss
All numbers in Millions USD
Helus Pharma Annual Profit & Loss
All numbers in Millions USD
Helus Pharma News & Key Events

Today's Timeline - 30 December
Wed, 02:03 AM
-Cybin launches an at-the-market equity program to issue up to US$100 million in common shares for growth and working capital.
Insights on Helus Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 1 month, CYBN stock has moved up by 38.2%
NO EFFECTAgainst Peers

In the last 3 years, Insmed Incorporated has given 797.3% return, outperforming this stock by 835.2%
NO EFFECTAgainst Peers

In the last 1 year, Insmed Incorporated has given 153.5% return, outperforming this stock by 171.5%
About Helus Pharma
| Organisation | Helus Pharma |
FAQs
What is Helus Pharma share price today?
Helus Pharma share price today is $8.32 as on at the close of the market. Helus Pharma share today touched a day high of $8.38 and a low of $8.14.
What is the 52 week high and 52 week low for Helus Pharma share?
Helus Pharma share touched a 52 week high of $9.12 on and a 52 week low of $5.50 on . Helus Pharma stock price today i.e. is closed at $8.32,which is 8.77% down from its 52 week high and 51.27% up from its 52 week low.
How to invest in Helus Pharma Stock (CYBN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Helus Pharma on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Helus Pharma Stock (CYBN) from India?
Indian investors can start investing in Helus Pharma (CYBN) shares with as little as ₹95.20999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.10 in Helus Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Helus Pharma share’s latest price of $8.32 as on January 3, 2026 at 2:29 am IST, you will get 1.2019 shares of Helus Pharma. Learn more about
fractional shares .